Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregory M Lucas

Showing results (151-160 of 174) with videos related to

Pageof 18
Sort By:
AIDS Care|March 28, 2025
People who inject drugs and men who have sex with men living with HIV in India experience low probability of viral rebound and high levels of persistent viremia during the first 12 months of antiretroviral therapyTalia A Loeb, Sunil S Solomon, Mihili P Gunaratne, et al.
Medrxiv : the Preprint Server for Health Sciences|February 6, 2026
Comparative Effectiveness of ACE Inhibitors and Angiotensin Receptor Blockers for Cardiovascular Disease Prevention in People Living with HIV and HypertensionTom Forzy, Henock G Yebyo, Gregory M Lucas, et al.
American Journal of Epidemiology|November 21, 2024
A precision randomized trial to evaluate the impact of tailored hepatitis C treatment adherence support on HCV treatment outcomes among people who inject drugs in India: Design and Baseline Characteristics of the STOP-C TrialShruti H Mehta, Bryan M Lau, Stephan Ehrhardt, et al.
Hepatology (Baltimore, Md.)|May 19, 2021
Spatiotemporal Phylodynamics of Hepatitis C Among People Who Inject Drugs in IndiaSteven J Clipman, Shruti H Mehta, Mary A Rodgers, et al.
The Lancet. HIV|April 7, 2024
Voucher incentives to improve viral suppression among HIV-positive people who inject drugs and men who have sex with men in India: a cluster randomised trialSunil S Solomon, Allison M McFall, Aylur K Srikrishnan, et al.
The Journal of Infectious Diseases|August 2, 2013
Hepatitis C viremia and the risk of chronic kidney disease in HIV-infected individualsGregory M Lucas, Yuezhou Jing, Mark Sulkowski, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 20, 2018
The North-South Divide: Substance Use Risk, Care Engagement, and Viral Suppression Among Hospitalized Human Immunodeficiency Virus-Infected Patients in 11 US CitiesMorgan M Philbin, Daniel J Feaster, Lauren Gooden, et al.
The Lancet. Infectious Diseases|December 10, 2014
Burden of hepatitis C virus disease and access to hepatitis C virus services in people who inject drugs in India: a cross-sectional studySunil Suhas Solomon, Shruti H Mehta, Aylur K Srikrishnan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 20, 2014
Clinical practice guideline for the management of chronic kidney disease in patients infected with HIV: 2014 update by the HIV Medicine Association of the Infectious Diseases Society of AmericaGregory M Lucas, Michael J Ross, Peter G Stock, et al.
Open Forum Infectious Diseases|July 18, 2024
Hepatitis B Virus in People who Inject Drugs and Men who Have Sex With Men With HIV in India: A Cross-sectional StudyTalia A Loeb, Mihili P Gunaratne, Syed Iqbal, et al.
Pageof 18

Showing results (151-160 of 174) with videos related to

Sort By:
Pageof 18
AIDS Care|March 28, 2025
People who inject drugs and men who have sex with men living with HIV in India experience low probability of viral rebound and high levels of persistent viremia during the first 12 months of antiretroviral therapyTalia A Loeb, Sunil S Solomon, Mihili P Gunaratne, et al.
Medrxiv : the Preprint Server for Health Sciences|February 6, 2026
Comparative Effectiveness of ACE Inhibitors and Angiotensin Receptor Blockers for Cardiovascular Disease Prevention in People Living with HIV and HypertensionTom Forzy, Henock G Yebyo, Gregory M Lucas, et al.
American Journal of Epidemiology|November 21, 2024
A precision randomized trial to evaluate the impact of tailored hepatitis C treatment adherence support on HCV treatment outcomes among people who inject drugs in India: Design and Baseline Characteristics of the STOP-C TrialShruti H Mehta, Bryan M Lau, Stephan Ehrhardt, et al.
Hepatology (Baltimore, Md.)|May 19, 2021
Spatiotemporal Phylodynamics of Hepatitis C Among People Who Inject Drugs in IndiaSteven J Clipman, Shruti H Mehta, Mary A Rodgers, et al.
The Lancet. HIV|April 7, 2024
Voucher incentives to improve viral suppression among HIV-positive people who inject drugs and men who have sex with men in India: a cluster randomised trialSunil S Solomon, Allison M McFall, Aylur K Srikrishnan, et al.
The Journal of Infectious Diseases|August 2, 2013
Hepatitis C viremia and the risk of chronic kidney disease in HIV-infected individualsGregory M Lucas, Yuezhou Jing, Mark Sulkowski, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 20, 2018
The North-South Divide: Substance Use Risk, Care Engagement, and Viral Suppression Among Hospitalized Human Immunodeficiency Virus-Infected Patients in 11 US CitiesMorgan M Philbin, Daniel J Feaster, Lauren Gooden, et al.
The Lancet. Infectious Diseases|December 10, 2014
Burden of hepatitis C virus disease and access to hepatitis C virus services in people who inject drugs in India: a cross-sectional studySunil Suhas Solomon, Shruti H Mehta, Aylur K Srikrishnan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 20, 2014
Clinical practice guideline for the management of chronic kidney disease in patients infected with HIV: 2014 update by the HIV Medicine Association of the Infectious Diseases Society of AmericaGregory M Lucas, Michael J Ross, Peter G Stock, et al.
Open Forum Infectious Diseases|July 18, 2024
Hepatitis B Virus in People who Inject Drugs and Men who Have Sex With Men With HIV in India: A Cross-sectional StudyTalia A Loeb, Mihili P Gunaratne, Syed Iqbal, et al.
Pageof 18